Pioglitazone trial for NASH: results show promise

L Lang - Gastroenterology, 2007 - gastrojournal.org
837 glitazone for patients with nonalcoholic steatohepatitis and to gain a better
understanding of the mechanisms involved during thiazolidinedione therapy.” In an
accompanying editorial, Dr. Arthur J. McCullough, Professor of Medicine at the Cleveland
Clinic Lerner College of Medicine at Case Western Reserve University and Director of
Gastroenterology and Hepatology at the Cleveland Clinic, states that although
thiazolidinediones have many benefits, including reduction of both insulin resistance and …
以上显示的是最相近的搜索结果。 查看全部搜索结果